Market Overview

Brean Capital Downgrade Endocyte, Inc. to Hold

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ECYT

DateFirmActionFromTo
Oct 2017WedbushUpgradesNeutralOutperform
Jun 2017Cowen & Co.DowngradesOutperformMarket Perform
Jun 2017WedbushDowngradesOutperformNeutral

View More Analyst Ratings for ECYT
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (ECYT)

Partner Center